We are inspiring human belief in a healthier world
Our founding mission is to make highly quality medicines affordable and accessible to the world
30 years of Service in the pharmaceutical industry, backed by proven track record in R&D excellence
Our mission to enable access to affordable medicines and improve lives flow from the top
Expanding our presence to serve more people and create meaningful impact
Being acknowledged for our efforts motivates our entire team
Our expertise across APIs, global generics, biosimilars and custom pharmaceutical services is secured by a strong R&D backbone
We have steadily invested in a wide range of innovations to make our product portfolio diverse and differentiated in a competitive market
The path to serving patients better
World-class and differentiated portfolio in chronic therapy areas
Achieving a sustainable health equity
Fully integrated services across the value chain
Committed to transforming standards of care
Researching areas of unmet medical need
Our expertise rest on the pillars of our advanced R&D capabilities, world-class manufacturing facilities, our long legacy of trust and our partnerships
Research excellence for us means to invest in the future of health for the world
We invest in cutting edge research to develop new cures for challenging diseases
Built to world-class standards, our facilities enable us to produce high-quality and affordable medicines
Legacy of trust
Growing better, together
We are committed to making a positive impact by contributing to healthy communities and leading a responsible business
Aiming for a sustainable environment
A constant focus on sustainable environment with focus on health and safety
A steadfast commitment to enable communities
Hetero aims to report comprehensively and transparently for all stakeholders
Find range of resources including press releases, featured stories and information on social media channels
Access our latest press releases and resources for News and Media section
Discover the stories that enumerate the way we understand disease and develop medicines
Latest media releases and statements in the Hetero newsroom
Browse and download multimedia resources for use
Notices
Back
Hyderabad, May 11, 2022: Hetero, Indiaās leading pharmaceutical company, today unveiled its new corporate logo, brand architecture, visual and verbal identity. With a people-first approach, this distinctive identity will guide and accelerate Heteroās business growth and evolution.
Dr. Vamsi Krishna Bandi, Managing Director, Hetero Group of Companies, said: āOur new logo, is built around the idea of āHealth for Allā and strengthens our ideology of 'focused interventions leading to exponential impact.' It uses circles as the primary visual anchor to represent the idea of accessibility and global reachā.
The new logo is a refreshing change from the version that has served Hetero well for three decades. And yet its reflection can be seen in the new version. It continues to be red but with a warmer tone that shows Heteroās passion and humane approach.
We defined why we exist in the form of a purpose statement, which is a reflection of our past, present and future. It is to keepā¦
At Hetero, our every action seeks to inspire human belief in accessibility and affordability of life-saving medicines across the world.
Dr. B. Partha Saradhi Reddy, Chairman, Hetero Group of Companies, said: āWith unparalleled strengths in research, manufacturing, and marketing, we have been well-positioned to serve people regardless of geographies. Our new identity embodies this drive to expand our reach and capabilities in order to respond with agility to the worldās evolving health needsā.
The new logo is effective immediately and will be implemented across the Groupās companies, solutions, assets, services, and products in due course.
About Hetero
Hetero is a globally renowned vertically integrated pharmaceutical organization engaged in research and development, manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas. Backed by 30 years of expertise in the pharmaceutical industry, Heteroās strategic business areas spread across APIs, Global Generics, Biosimilars and Custom Pharmaceutical Services. The company is among the largest producers of Active Pharmaceutical Ingredients (APIs) in the world. For more information on Hetero, please visit www.hetero.com.
For further details, please contact:
SreeRam Banda Head - Corporate Communications, Hetero Mobile: 97036 20166 Email: sreeram.b@hetero.com